about
Nestin expression in the cell lines derived from glioblastoma multiforme.Nestin as a marker of cancer stem cellsCase report: rapid and durable response to PDGFR targeted therapy in a child with refractory multiple infantile myofibromatosis and a heterozygous germline mutation of the PDGFRB gene.Non-DHFR-mediated effects of methotrexate in osteosarcoma cell lines: epigenetic alterations and enhanced cell differentiationCo-Expression of Cancer Stem Cell Markers Corresponds to a Pro-Tumorigenic Expression Profile in Pancreatic AdenocarcinomaNestin expression in human tumors and tumor cell lines.Cancer stem cell markers in pediatric sarcomas: Sox2 is associated with tumorigenicity in immunodeficient mice.Atypical nuclear localization of CD133 plasma membrane glycoprotein in rhabdomyosarcoma cell lines.DHFR-mediated effects of methotrexate in medulloblastoma and osteosarcoma cells: the same outcome of treatment with different doses in sensitive cell lines.Much more than you expected: The non-DHFR-mediated effects of methotrexate.EGFR signaling in the HGG-02 glioblastoma cell line with an unusual loss of EGFR gene copy.An unusual loss of EGFR gene copy in glioblastoma multiforme in a child: a case report and analysis of a successfully derived HGG-02 cell line.Expression of nestin, CD133 and ABCG2 in relation to the clinical outcome in pediatric sarcomas.Reaction of the skin fibroblast cytoskeleton to micromanipulation interventions.Why Differentiation Therapy Sometimes Fails: Molecular Mechanisms of Resistance to Retinoids.The optimization of sample treatment for spectral karyotyping with applications for human tumour cells.CD133 expression and identification of CD133/nestin positive cells in rhabdomyosarcomas and rhabdomyosarcoma cell lines.[Profile of Activation of Tyrosine Kinases and MAP Kinases in Therapy of Maffucci Syndrome].Low-level copy number changes of MYC genes have a prognostic impact in medulloblastoma.Traffic lights for retinoids in oncology: molecular markers of retinoid resistance and sensitivity and their use in the management of cancer differentiation therapyEffects of Sunitinib and Other Kinase Inhibitors on Cells Harboring a Mutation Associated with Infantile MyofibromatosisPrediction of neuroblastoma cell response to treatment with natural or synthetic retinoids using selected protein biomarkers.Nestin expression in high-grade osteosarcomas and its clinical significance[Functional assays for detection of cancer stem cells][Tumor microenvironment - possibilities of the research under in vitro conditions]Cancer stem cells in sarcomas: Getting to the stemness coreSerial Xenotransplantation in NSG Mice Promotes a Hybrid Epithelial/Mesenchymal Gene Expression Signature and Stemness in Rhabdomyosarcoma CellsPharmacological targeting of mitochondria in cancer stem cells: An ancient organelle at the crossroad of novel anti-cancer therapiesRepurposing Tyrosine Kinase Inhibitors to Overcome Multidrug Resistance in Cancer: A Focus on Transporters and Lysosomal Sequestration
P50
Q25255381-A97CC3DC-C89A-4A1A-ABC8-3FB49AE5479AQ26851514-14CBB303-C1E9-430C-AFEC-8190BE60D76AQ36276051-8585B928-BCFE-46B5-ADEF-FD0049BAA910Q36628909-AAD35CB9-76ED-43F3-B107-1F7EB3FADB3DQ37095091-1E6CEE31-DE9C-4B72-8009-D8E68B68C678Q37739407-47085DF4-E565-4FC6-9559-850C4408A84FQ38801373-83728EFE-3B55-41E7-8EB6-26898FEBE38FQ38874577-C9CDD183-97B5-4EEC-8EFD-98AFE5D76F67Q38903608-59A9AE1D-0652-44A2-8820-B162F20970B3Q39043691-D84B954D-9D0A-4F0C-AD26-69DC693E68A5Q39056382-66CB65C8-13F3-4258-A549-464B78AF4031Q39733476-D5DB5E92-F941-4838-9BFE-96657E908326Q40695629-E005C710-B38A-4977-9FF4-B9C13A7E703BQ40745684-C7FC2E2D-9CAD-464D-8DF2-BB3CA14A5E1CQ49538563-910D577B-F034-4FA2-A29B-B45FEC65A47DQ53569529-0A74C88C-89A5-4360-AB83-E27158B018FAQ53916577-2004A594-4057-48CD-B5D5-B865B39B6E70Q54246272-5FE86B29-07BD-46FB-ACD7-92B1450C3CF4Q55463984-4827EE66-266E-4CF7-AFFF-AC012E91B696Q58544569-EB1609EA-1316-4A3B-B521-99DE309A7D6CQ58773530-8749D0ED-5872-462F-AC37-369DB5114735Q64906838-57127486-BC2F-4CF9-856E-7FB1F5F714D9Q83465580-EEA75731-50D4-4564-83A0-6DF92B24BB2FQ88111587-60865D88-246C-49DC-9E94-2B9E2C60F00CQ88111591-80F8A912-2F74-4810-BF40-5EC9A1CCF0B8Q90024256-6124F46B-DEEA-494A-BB54-39F3F357D885Q92663085-147530DC-884C-426E-B069-46CD37DB29D0Q93213209-927F276C-3091-4B0F-BC79-12E505F5E3FCQ94515395-D87FB9E0-AEEB-4E79-8AEB-B7B1EE9D2424
P50
description
researcher ORCID ID = 0000-0002-0048-9913
@en
wetenschapper
@nl
name
Renata Veselska
@ast
Renata Veselska
@en
Renata Veselska
@es
Renata Veselska
@nl
type
label
Renata Veselska
@ast
Renata Veselska
@en
Renata Veselska
@es
Renata Veselska
@nl
prefLabel
Renata Veselska
@ast
Renata Veselska
@en
Renata Veselska
@es
Renata Veselska
@nl
P1153
6603289820
P21
P31
P496
0000-0002-0048-9913